Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Part of paid clinical trials in Los Angeles, California.

Sponsor
Jonsson Comprehensive Cancer Center
Study ID
NCT00301990
Phase
PHASE2
Status
Unknown

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Bevacizumab may also stop the growth of tumor cells by blocking blood flow to the tumor. Interleukin-2 may stimulate the white blood cells to kill tumor cells. Giving bevacizumab together with interleukin-2 may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving bevacizumab together with interleukin-2 works in treating patients with metastatic kidney cancer.

Key Dates

First listed
Mar 13, 2006
Start date
Sep 30, 2005
Status verified
Apr 2007

Study Design

Enrollment
65 participants (estimated)
Primary purpose
TREATMENT

Primary Outcome Measure

Response

Locations (11)

FacilityCityStateZIPSite coordinators
Jonsson Comprehensive Cancer Center at UCLALos AngelesCalifornia90095-1781
Clinical Trials Office - Jonsson Comprehensive Cancer Center a
888-798-0719
Cardinal Bernardin Cancer Center at Loyola University Medical CenterMaywoodIllinois60153
Clinical Trials Office - Cardinal Bernardin Cancer Center
708-226-4357
Indiana University Melvin and Bren Simon Cancer CenterIndianapolisIndiana46202-5289
Clinical Trials Office - Indiana University Cancer Center
317-274-2552
Beth Israel Deaconess Medical CenterBostonMassachusetts02215
Clinical Trials Office - Beth Israel Deaconess Medical Center
617-667-9925
Barbara Ann Karmanos Cancer InstituteDetroitMichigan48201-1379
Clinical Trials Office - Barbara Ann Karmanos Cancer Institute
313-576-9363
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical CenterLebanonNew Hampshire03756-0002
Clinical Trials Office - Norris Cotton Cancer Center
[email protected]
603-650-7609
Our Lady of Mercy Medical Center Comprehensive Cancer CenterThe BronxNew York10466
Janice P. Dutcher, MD
718-304-7200
Providence Cancer Center at Providence Portland Medical CenterPortlandOregon97213-2967
Clinical Trials Office - Providence Cancer Center at Providenc
503-215-6412
UPMC Cancer CentersPittsburghPennsylvania15232
Clinical Trials Office - UPMC Cancer Centers
412-647-8073
Vanderbilt-Ingram Cancer CenterNashvilleTennessee37232-6838
Clinical Trials Office - Vanderbilt-Ingram Cancer Center
800-811-8480
University of Virginia Cancer CenterCharlottesvilleVirginia22908
Geoffrey R. Weiss, MD
[email protected]
434-243-0066

Find similar trials in Los Angeles, CA

By condition
Kidney cancer
By specialty
OncologyUrology
By research site
Jonsson Comprehensive Cancer Center at UCLA· Los Angeles, CACardinal Bernardin Cancer Center at Loyola University Medical Center· Maywood, ILIndiana University Melvin and Bren Simon Cancer Center· Indianapolis, INBeth Israel Deaconess Medical Center· Boston, MABarbara Ann Karmanos Cancer Institute· Detroit, MINorris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center· Lebanon, NH

Related Studies